CAMBRIDGE, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical stage biotechnology company pioneering a new class of medicines that treat serious diseases ...
When Cigall Kadoch was a teenager, a close family friend was diagnosed with late-stage breast cancer. As Kadoch processed the news, she became deeply frustrated. “I didn’t understand what cancer was, ...
A decade ago, when Cigall Kadoch joined Gerald Crabtree’s lab at Stanford University, she was an odd fit: the incoming graduate student was determined to do cancer research, but at the time, ...
New research from Dana-Farber Cancer Institute researcher Cigall Kadoch, PhD, along with colleagues at Princeton University and the Washington University in St. Louis, reveals a key role for ...
Advancing the understanding of synovial sarcoma, a highly aggressive and rare cancer of young people, scientists at Dana-Farber Cancer Institute have discovered how an abnormal protein misdirects and ...
Researchers have identified a group of proteins that are mutated in about one-fifth of all human cancers. The finding suggests that the proteins, which are members of a protein complex that affects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results